… eslicarbazepine acetate in the treatment of drug-resistant partial epilepsy. Efficacy and safety
… Eslicarbazepine acetate is not recommended below 18 years, but a published phase II trial …

… Eslicarbazepine acetate is a is a once-daily antiepileptic … The eslicarbazepine acetate
development program included an … have consistently shown that eslicarbazepine acetate (800 to …

… Eslicarbazepine acetate is a third-generation antiepileptic … the efficacy, tolerability and safety
of eslicarbazepine for TN. … hypothesis that eslicarbazepine acetate is an effective, safe and …

… This article reports on the efficacy and safety of one of the three pivotal studies with ESL as
… Note: p-values are based on comparison between eslicarbazepine acetate (ESL) groups and …

Purpose: To evaluate the long‐term efficacy and safety of once daily eslicarbazepine acetate
(ESL) as adjunctive therapy for partial‐onset seizures in adults with epilepsy. Methods: One…

… A, Responder rate (ie, proportion of patients with at least 50% decrease in number of seizures)
and; B, proportion of seizure-free patients in a phase II study with eslicarbazepine acetate …

Purpose: To evaluate the efficacy and safety profile of eslicarbazepine acetate (ESL) added
to stable antiepileptic therapy in adults with partial‐onset seizures. Methods: Data from …

… evaluate the efficacy and safety of eslicarbazepine acetate (… Eslicarbazepine acetate (ESL)
is a novel voltage-gated … is rapidly and extensively metabolized to eslicarbazepine (the entity …

Objective We assessed the efficacy and safety of once‐daily eslicarbazepine acetate in
comparison with twice‐daily ( BID ) controlled‐release carbamazepine (carbamazepine‐ CR ) …

… Pooled evaluation of the key efficacy and safety profile of eslicarbazepine acetate (ESL) …
Eslicarbazepine acetate is metabolized initially solely to eslicarbazepine and then subsequently …